<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01599559</url>
  </required_header>
  <id_info>
    <org_study_id>IELSG37</org_study_id>
    <nct_id>NCT01599559</nct_id>
  </id_info>
  <brief_title>Randomized, Open-label, Two-arms, Phase III Comparative Study Assessing the Role of Involved Mediastinal Radiotherapy After Rituximab Containing Chemotherapy Regimens to Patients With Newly Diagnosed Primary Mediastinal Large B-Cell Lymphoma</brief_title>
  <official_title>IELSG37: A Randomized, Open-label, Multicentre, Two-arm Phase III Comparative Study Assessing the Role of Involved Mediastinal Radiotherapy After Rituximab Containing Chemotherapy Regimens to Patients With Newly Diagnosed Primary Mediastinal Large B-Cell Lymphoma (PMLBCL)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>International Extranodal Lymphoma Study Group (IELSG)</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>International Extranodal Lymphoma Study Group (IELSG)</source>
  <brief_summary>
    <textblock>
      Primary mediastinal large B cell lymphoma is treated with a combination of chemotherapy and
      the monoclonal antibody rituximab (chemoimmunotherapy).

      Following chemoimmunotherapy patients receive radiation therapy if they have residues which
      may be active tumour. However at the end of chemoimmunotherapy the majority of patients show
      tissue scarring that is not necessarily active tumor. In recent years, PET/CT has proved to
      be a good tool to accurately identify active tumor from scar tissue in patients treated for
      mediastinal lymphoma.The purpose of this trial is to test whether radiation therapy is really
      necessary in patients where PET/CT has shown that the tumor is no longer active. Therefore we
      will compare radiation treatment with careful observation.

      Patients that at the end of conventional treatment of chemoimmunotherapy have a negative
      PET/CT (i.e., without residues suspected to contain active tumor), will randomly assigned to
      two different treatment groups: one treatment group will receive the radiation treatment, and
      the other treatment group will receive careful observation.

      The trial is planned according to a non-inferiority design aimed at demonstrating that
      progression free survival after the experimental treatment (observation) is not worse than
      after the standard comparator (mediastinal irradiation.Participation in this study could
      spare patients with complete remission at the end of chemo immunotherapy (PET/CT negative)
      radiation therapy that may be unnecessary.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2011</start_date>
  <completion_date type="Anticipated">May 2025</completion_date>
  <primary_completion_date type="Actual">May 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Progression free survival (PFS)</measure>
    <time_frame>2 years from the randomization</time_frame>
    <description>The primary outcome endpoint will be Progression Free Survival (PFS) in patients PET-negative after R-chemotherapy.
Failure events for PFS are progression (defined as an increase in size of existing masses or the development of new sites of disease using the same radiological investigations CT or PET/CT and/or MRI - as for the pre-chemotherapy assessment) or death from any cause.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Overall survival (OS)</measure>
    <time_frame>5 years from registration</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">540</enrollment>
  <condition>Primary Mediastinal B-cell Lymphoma</condition>
  <arm_group>
    <arm_group_label>observation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Follow up visits are scheduled from randomization. Patients will be seen at 3-months intervals for 24 months, then every 6 months until 5 years from randomization.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>mediastinal irradiation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Radiotherapy will be delivered in this phase III protocol, as alternative to observation, as consolidation treatment in patients achieving a CR status (PET/CT scan negative) at the end of R-chemotherapy, with a total dose of 30 Gy.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>observation</intervention_name>
    <description>observation</description>
    <arm_group_label>observation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>3D-Conformal Radiotherapy (3D-CRT)</intervention_name>
    <description>Radiation treatment should start within 6-8 weeks after the end of chemotherapy.</description>
    <arm_group_label>mediastinal irradiation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Previously untreated primary mediastinal diffuse large B-cell lymphoma, CD20 positive.

          -  Patients must have histological confirmation of the diagnosis (it is recommended that
             the immunohistochemical panel includes: CD45, CD20, CD30, CD15, CD10, BCL6, BCL2,
             MUM-1), and in addition have a dominant mass within the anterior mediastinum.

          -  No evidence of extranodal disease outside the chest including spleen and bone marrow.

          -  Age at least 18 years.

          -  Fit to receive chemotherapy and radiotherapy with curative intent.

          -  Patients will be eligible if the treatment phase consisting in a Rituximab combined
             with any anthracycline-containing chemotherapy regimen without consolidation with
             autologous stem cell support (e.g., 6 cycles of CHOP14-21, DA-EPOCH, Mega-CHOP or 12
             weeks of VACOP-B or MACOP-B).

          -  At least 6 courses of Rituximab should be administered

          -  Able and willing to give informed consent, and to undergo staging including PET
             scanning

          -  Willingness to comply with an appropriate contraceptive method in women of
             childbearing potential or men.

          -  Histological diagnostic material available for review.

        Exclusion Criteria:

          -  History of malignancy other than squamous cell carcinoma, basal cell carcinoma of the
             skin or carcinoma in situ of the cervix within the last 5 years.

          -  Evidence of clinically significant cardiac disease at diagnosis, as defined by history
             of symptomatic ventricular arrhythmias, congestive heart failure or myocardial
             infarction within 12 months before study entry. Cardiac impairment due to local
             extension of lymphoma will not be an exclusion criterion in the absence of other
             cardiac disease.

          -  Known HIV-positive serology.

          -  Pregnant or lactating women.

          -  Any psychological, familial, sociological or geographical condition potentially
             hampering compliance with the study protocol and follow-up schedule.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Maurizio Martelli, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Università La Sapienza (Rome - Italy)</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Andrew J Davies, MD</last_name>
    <role>Study Chair</role>
    <affiliation>University of Southampton (UK)</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mary Gospodarowicz, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Princess Margaret Hospital Toronto (Canada)</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Sally F Barrington, MD</last_name>
    <role>Study Chair</role>
    <affiliation>St. Thomas' - London (UK)</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Alberto Biggi, MD</last_name>
    <role>Study Chair</role>
    <affiliation>AO S. Croce e Carle, Cuneo (Italia)</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Annibale Versari, MD</last_name>
    <role>Study Chair</role>
    <affiliation>S.Maria Nuova Hospital, Reggio Emilia (Italia)</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Gianni Ciccone, MD</last_name>
    <role>Study Chair</role>
    <affiliation>CPO Torino (Italy)</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Stèphane Chauvie, MD</last_name>
    <role>Study Chair</role>
    <affiliation>AO S. Crtoce e Carle - Cuneo (Italy)</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Luca Ceriani, MD</last_name>
    <role>Study Chair</role>
    <affiliation>IOSI - Bellinzona (Switzerland)</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Emanuele Zucca, MD</last_name>
    <phone>++41 91 811 90 40</phone>
    <email>ielsg@eoc.ch</email>
  </overall_contact>
  <location>
    <facility>
      <name>Norton Cancer Institute</name>
      <address>
        <city>Louisville</city>
        <state>Kentucky</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>DON STEVENS, MD</last_name>
    </contact>
    <investigator>
      <last_name>DON STEVENS, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mayo Clinil Rocheser</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Grzegorz Nowakowski</last_name>
    </contact>
    <investigator>
      <last_name>Grzegorz Nowakowski</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centro de Hematologia y Oncologia Pavlovsky</name>
      <address>
        <city>Buenos Aires</city>
        <country>Argentina</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Astrid Pavlovski</last_name>
    </contact>
    <investigator>
      <last_name>Astrid Pavlovski</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Princess Margaret Hospital</name>
      <address>
        <city>Toronto</city>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David Hodgson, MD</last_name>
    </contact>
    <investigator>
      <last_name>David Hodgson</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Duisburg-Essen, Campus Essen</name>
      <address>
        <city>Essen</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andreas Hüttmann, MD</last_name>
    </contact>
    <investigator>
      <last_name>Andreas Hüttmann, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>A.O. SS. Antonio e Biagio e Cesare Arrigo</name>
      <address>
        <city>Alessandria</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Flavia Salvi, MD</last_name>
    </contact>
    <investigator>
      <last_name>Flavia Salvi</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Clinica di Ematologia Ospedali Riuniti &quot;Umberto I&quot;</name>
      <address>
        <city>Ancona</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Guido Gini</last_name>
    </contact>
    <investigator>
      <last_name>Guido Gini</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centro di Riferimento Oncologico - Aviano</name>
      <address>
        <city>Aviano</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michele Spina</last_name>
    </contact>
    <investigator>
      <last_name>Michele Spina</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>A.O.U Policlinico Consorziale di Bari</name>
      <address>
        <city>Bari</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Giorgina Specchia, Prof</last_name>
    </contact>
    <investigator>
      <last_name>Giorgina Specchia, Prof</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Bari IRCCS Istituto Tumori</name>
      <address>
        <city>Bari</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Attilio Guarini</last_name>
    </contact>
    <investigator>
      <last_name>Attilio Guarini</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ospedale Papa Giovanni Xxiii</name>
      <address>
        <city>Bergamo</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>ALESSANDRO RAMBALDI, PROF</last_name>
    </contact>
    <investigator>
      <last_name>ALESSANDRO RAMBALDI, PROF</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sant'Orsola Malpighi</name>
      <address>
        <city>Bologna</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vittorio Stefoni</last_name>
    </contact>
    <investigator>
      <last_name>Vittorio Stefoni</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Comprensorio Sanitario di Bolzano</name>
      <address>
        <city>Bolzano</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Atto Billio</last_name>
    </contact>
    <investigator>
      <last_name>Atto Billio</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Spedali Civili</name>
      <address>
        <city>Brescia</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Giuseppe Rossi</last_name>
    </contact>
    <investigator>
      <last_name>Giuseppe Rossi</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Asl Uoc Ematologia A Perrino</name>
      <address>
        <city>Brindisi</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>ANGELA MELPIGNANO, MD</last_name>
    </contact>
    <investigator>
      <last_name>ANGELA MELPIGNANO, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ospedale Businco</name>
      <address>
        <city>Cagliari</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Giuseppina Cabras</last_name>
    </contact>
    <investigator>
      <last_name>Giuseppina Cabras</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>AO Garibaldi Nesima Catalia</name>
      <address>
        <city>Catania</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ugo Consoli</last_name>
    </contact>
    <investigator>
      <last_name>Ugo Consoli</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Unità Funzionale di Ematologia AOU Careggi</name>
      <address>
        <city>Firenze</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alberto Bosi</last_name>
    </contact>
    <investigator>
      <last_name>Alberto Bosi</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>U.O. Ematologia Vito Fazzi</name>
      <address>
        <city>Lecce</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nicola DI RenzO</last_name>
    </contact>
    <investigator>
      <last_name>Nicola DI RenzO</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori</name>
      <address>
        <city>Meldola</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gerardo Musuraca</last_name>
    </contact>
    <investigator>
      <last_name>Gerardo Musuraca</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>SC Ematologia Azienda Ospedali Riuniti Papardo Piemonte</name>
      <address>
        <city>Messina</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Donato Mannina</last_name>
    </contact>
    <investigator>
      <last_name>Donato Mannina</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Istituto Scientifico San Raffaele</name>
      <address>
        <city>Milano</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andrés Ferreri, MD</last_name>
    </contact>
    <investigator>
      <last_name>Andrées Ferreri, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Milano Ieo</name>
      <address>
        <city>Milano</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>CORRADO TARELLA, MD</last_name>
    </contact>
    <investigator>
      <last_name>CORRADO TARELLA, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>SC Ematologia AO Niguarda</name>
      <address>
        <city>Milano</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chiara Rusconi, MD</last_name>
    </contact>
    <investigator>
      <last_name>Chiara Rusconi</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>AOU Policlinico di Modena</name>
      <address>
        <city>Modena</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>SAMANTHA POZZI, MD</last_name>
    </contact>
    <investigator>
      <last_name>SAMANTHA POZZI, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ematologia Università degli Studi di Federico II</name>
      <address>
        <city>Napoli</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amalia De Renzo</last_name>
    </contact>
    <investigator>
      <last_name>Amalia De RenzO</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ospedale Umberto I</name>
      <address>
        <city>Nocera</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>CATELLO CALIFANO, MD</last_name>
    </contact>
    <investigator>
      <last_name>CATELLO CALIFANO, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliera Universitaria</name>
      <address>
        <city>Padova</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>FRANCESCO PIAZZA, MD</last_name>
    </contact>
    <investigator>
      <last_name>FRANCESCO PIAZZA, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ospedali Riuniti Villa Sofia</name>
      <address>
        <city>Palermo</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Caterina Patti</last_name>
    </contact>
    <investigator>
      <last_name>Caterina Patti</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>AOU di Parma</name>
      <address>
        <city>Parma</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Francesca Re</last_name>
    </contact>
    <investigator>
      <last_name>Francesca Re</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Fondazione IRCCS S. Matteo</name>
      <address>
        <city>Pavia</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Luca Arcaini, PROF</last_name>
    </contact>
    <investigator>
      <last_name>Luca Arcaini, PROF</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>S.C. Ematologia Ospedale S. Marid Della Misericordia</name>
      <address>
        <city>Perugia</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>LEONARDO FLENGHI, MD</last_name>
    </contact>
    <investigator>
      <last_name>LEONARDO FLENGHI, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ospedale Civico Guglielmo di Saliceto</name>
      <address>
        <city>Piacenza</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Daniele Vallisa</last_name>
    </contact>
    <investigator>
      <last_name>Daniele Vallisa</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>U.O. Oncologia Ematologia Ospedale S. Maria Delle Croci</name>
      <address>
        <city>Ravenna</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>CLAUDIA CELLINI, MD</last_name>
    </contact>
    <investigator>
      <last_name>CLAUDIA CELLINI, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>A.O. Bianchi-Melacrino-Morelli, Divisione di Ematologia</name>
      <address>
        <city>Reggio Calabria</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Caterina Stelitano, MD</last_name>
    </contact>
    <investigator>
      <last_name>Caterina Stelitano</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>ICCRS Azienda Ospedaliera Arcipedale &quot;Santa Maria Nuova&quot;</name>
      <address>
        <city>Reggio Emilia</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Francesco Merli</last_name>
    </contact>
    <investigator>
      <last_name>Francesco Merli</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ospedale Degli Infermi</name>
      <address>
        <city>Rimini</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>ANNALIA MOLINARI, MD</last_name>
    </contact>
    <investigator>
      <last_name>ANNALIA MOLINARI, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>AO San Camillo Forlanini</name>
      <address>
        <city>Roma</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Roberta Battistini</last_name>
    </contact>
    <investigator>
      <last_name>Roberto Battistini</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>AOU S. Andrea Roma</name>
      <address>
        <city>Roma</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maria Christina Cox</last_name>
    </contact>
    <investigator>
      <last_name>Maria Christina Cox</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ospedale S. Eugenio</name>
      <address>
        <city>Roma</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Elisabetta Abruzzese</last_name>
    </contact>
    <investigator>
      <last_name>Elisabetta Abruzzese</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Roma Regina Elena IFO</name>
      <address>
        <city>Roma</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Francesco Pisani</last_name>
    </contact>
    <investigator>
      <last_name>Francesco Pisani</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Roma San Giovanni</name>
      <address>
        <city>Roma</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Paola Anticoli</last_name>
    </contact>
    <investigator>
      <last_name>Paola Anticoli</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Università degli Studi La Sapienza</name>
      <address>
        <city>Roma</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maurizio Martelli, MD</last_name>
    </contact>
    <investigator>
      <last_name>Maurizio Martelli</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Rozzano Humanitas</name>
      <address>
        <city>Rozzano</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Monica Balzarotti</last_name>
    </contact>
    <investigator>
      <last_name>Monica Balzarotti</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Siena</name>
      <address>
        <city>Siena</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alberto Fabbri</last_name>
    </contact>
    <investigator>
      <last_name>Alberto Fabbri</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>AOS Maria di Terni</name>
      <address>
        <city>Terni</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anna Marina Liberati</last_name>
    </contact>
    <investigator>
      <last_name>Anna Marina Liberati</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>AOS S. Giovanni Battista &quot;Molinette&quot;</name>
      <address>
        <city>Torino</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Umberto Vitolo</last_name>
    </contact>
    <investigator>
      <last_name>Umberto Vitolo</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliera Citta Della Salute E Della Scienza Di Torino</name>
      <address>
        <city>Torino</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>FEDERICA CAVALLO, MD</last_name>
    </contact>
    <investigator>
      <last_name>FEDERICA CAVALLO, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ospedale Cardinale Panico</name>
      <address>
        <city>Tricase</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vincenzo Pavone</last_name>
    </contact>
    <investigator>
      <last_name>Vincenzo Pavone</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliera Univesritaria</name>
      <address>
        <city>Udine</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Francesco Zaja</last_name>
    </contact>
    <investigator>
      <last_name>Francesco Zaja</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Asst Settelaghi Ospedale Macchi</name>
      <address>
        <city>Varese</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>VINCENZO PASSAMONTI, MD</last_name>
    </contact>
    <investigator>
      <last_name>VINCENZO PASSAMONTI, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ospedale dell'Angelo</name>
      <address>
        <city>Venezia Mestre</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Renato Bassan</last_name>
    </contact>
    <investigator>
      <last_name>Renato Bassan</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Samsung Cancer Center</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>KIM WON SEOG, MD</last_name>
    </contact>
    <investigator>
      <last_name>KIM WON SEOG, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Oslo University Hospital</name>
      <address>
        <city>Oslo</city>
        <country>Norway</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexander Fossa, MD</last_name>
    </contact>
    <investigator>
      <last_name>Alexander Fossa</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St Olavs Hospital</name>
      <address>
        <city>Trondheim</city>
        <country>Norway</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Unn-Merete Fagerli, MD</last_name>
    </contact>
    <investigator>
      <last_name>Unn-Merete Fagerli</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Warsaw Centrum Onkologi Instytucie</name>
      <address>
        <city>Warsaw</city>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anna Dabrowska-Iwanicka, MD</last_name>
    </contact>
    <investigator>
      <last_name>Anna Dabrowska-Iwanicka, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Istituto Portugues de Oncologia de Lisboa</name>
      <address>
        <city>Lisboa</city>
        <country>Portugal</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>MARIA GOMES DA SILVA, MD</last_name>
    </contact>
    <investigator>
      <last_name>MARIA GOMES DA SILVA, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Lund Universitet</name>
      <address>
        <city>Lund</city>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mats Jerkeman</last_name>
    </contact>
    <investigator>
      <last_name>Mats Jerkeman</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>IOSI</name>
      <address>
        <city>Bellinzona</city>
        <zip>6500</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Emanuele Zucca, MD</last_name>
    </contact>
    <investigator>
      <last_name>Emanuele Zucca, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Inselspital Bern</name>
      <address>
        <city>Bern</city>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Codruta Ionescu, MD</last_name>
    </contact>
    <investigator>
      <last_name>Codruta Ionescu</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kantonsspital Olten</name>
      <address>
        <city>Olten</city>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>WALTER MINGRONE, MD</last_name>
    </contact>
    <investigator>
      <last_name>WALTER MINGRONE, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kantonsspital</name>
      <address>
        <city>St Gallen</city>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Felicitas Hitz, MD</last_name>
    </contact>
    <investigator>
      <last_name>Felicitas Hitz</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kyiv National Cancer Institute</name>
      <address>
        <city>Kiev</city>
        <country>Ukraine</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Irina Kryachok</last_name>
    </contact>
    <investigator>
      <last_name>Irina Kryachok</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>National Cancer Institute</name>
      <address>
        <city>Kyiv</city>
        <country>Ukraine</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Irina Kryachok, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Basingstoke &amp; North Hamptshire Hospital</name>
      <address>
        <city>Basingstoke</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alison Milne</last_name>
    </contact>
    <investigator>
      <last_name>Alison Milne</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Birmingham Heartlands Hospital</name>
      <address>
        <city>Birmingham</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>SHANKARA PANEESHA, MD</last_name>
    </contact>
    <investigator>
      <last_name>SHANKARA PANEESHA, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Royal Cornwall Hospital</name>
      <address>
        <city>Cornwall</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>ANTON KRUGER, MD</last_name>
    </contact>
    <investigator>
      <last_name>ANTON KRUGER, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hospital Coventry &amp; Warwickshire NHS Trust</name>
      <address>
        <city>Coventry</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clive Irvin</last_name>
    </contact>
    <investigator>
      <last_name>Clive Irvin</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Derriford Hospital</name>
      <address>
        <city>Derriford</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Simon Rule</last_name>
    </contact>
    <investigator>
      <last_name>Simon Rule</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Glasgow Beatson Cancer Center</name>
      <address>
        <city>Glasgow</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pam Mc Kay</last_name>
    </contact>
    <investigator>
      <last_name>Pam Mc Kay</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Leeds St. James's Hospital</name>
      <address>
        <city>Leeds</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rod Johnson</last_name>
    </contact>
    <investigator>
      <last_name>Rod Johnson</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Royal Liverpool University Hospital</name>
      <address>
        <city>Liverpool</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>ANDREW PETTITT, MD</last_name>
    </contact>
    <investigator>
      <last_name>ANDREW PETTITT, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Guy's &amp; St. Thomas London</name>
      <address>
        <city>London</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>George Mikhaeel</last_name>
    </contact>
    <investigator>
      <last_name>George Mikhaeel</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>UCLH St. Thomas</name>
      <address>
        <city>London</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>KATE CWYNARSKI, MD</last_name>
    </contact>
    <investigator>
      <last_name>KATE CWYNARSKI, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Manchester The Christie NHS Foundation Trust</name>
      <address>
        <city>Manchester</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tim Illdge</last_name>
    </contact>
    <investigator>
      <last_name>Tim Illdge</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Newcastle Freeman Hospital</name>
      <address>
        <city>Newcastle</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anne Lennard</last_name>
    </contact>
    <investigator>
      <last_name>Anne Lennard</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Norfolk &amp; Norwich University Hospital</name>
      <address>
        <city>Norfolk</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>HELEN STUBBINGS, MD</last_name>
    </contact>
    <investigator>
      <last_name>HELEN STUBBINGS, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Nottingham University Hospital</name>
      <address>
        <city>Nottingham</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>CHRISTOPHER FOX, MD</last_name>
    </contact>
    <investigator>
      <last_name>CHRISTOPHER FOX, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>General Hospital</name>
      <address>
        <city>Southampton</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andrew Davies, MD</last_name>
    </contact>
    <investigator>
      <last_name>Andrew Davies</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Argentina</country>
    <country>Canada</country>
    <country>Germany</country>
    <country>Italy</country>
    <country>Korea, Republic of</country>
    <country>Norway</country>
    <country>Poland</country>
    <country>Portugal</country>
    <country>Sweden</country>
    <country>Switzerland</country>
    <country>Ukraine</country>
    <country>United Kingdom</country>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 10, 2012</study_first_submitted>
  <study_first_submitted_qc>May 15, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 16, 2012</study_first_posted>
  <last_update_submitted>August 22, 2017</last_update_submitted>
  <last_update_submitted_qc>August 22, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 23, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>previously</keyword>
  <keyword>untreated</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lymphoma</mesh_term>
    <mesh_term>Lymphoma, B-Cell</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Rituximab</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

